These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31285247)

  • 1. ITU patients with delirium did not benefit from electronic and pharmacist support encouraging the deprescribing of benzodiazepines and anticholinergics.
    Donaghy J
    Evid Based Nurs; 2020 Apr; 23(2):52. PubMed ID: 31285247
    [No Abstract]   [Full Text] [Related]  

  • 2. Deprescribing in the Pharmacologic Management of Delirium: A Randomized Trial in the Intensive Care Unit.
    Campbell NL; Perkins AJ; Khan BA; Gao S; Farber MO; Khan S; Wang S; Boustani MA
    J Am Geriatr Soc; 2019 Apr; 67(4):695-702. PubMed ID: 30664239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacist interventions to deprescribe benzodiazepines in older adults: A missed opportunity?
    Cadogan CA
    Res Social Adm Pharm; 2022 Nov; 18(11):4012-4015. PubMed ID: 35768308
    [No Abstract]   [Full Text] [Related]  

  • 4. Health Care Practitioners' Perspectives on Deprescribing Anticholinergic and Sedative Medications in Older Adults.
    Kouladjian L; Gnjidic D; Reeve E; Chen TF; Hilmer SN
    Ann Pharmacother; 2016 Aug; 50(8):625-36. PubMed ID: 27257284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deprescribing anticholinergic and sedative medicines: protocol for a Feasibility Trial (DEFEAT-polypharmacy) in residential aged care facilities.
    Ailabouni N; Mangin D; Nishtala PS
    BMJ Open; 2017 Apr; 7(4):e013800. PubMed ID: 28416498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deprescribing Benzodiazepines in Older Patients: Impact of Interventions Targeting Physicians, Pharmacists, and Patients.
    Ng BJ; Le Couteur DG; Hilmer SN
    Drugs Aging; 2018 Jun; 35(6):493-521. PubMed ID: 29705831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A realist evaluation of patients' decisions to deprescribe in the EMPOWER trial.
    Martin P; Tannenbaum C
    BMJ Open; 2017 May; 7(4):e015959. PubMed ID: 28473524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Pharmacist-led Deprescribing Intervention with the Functional Recovery in Convalescent Setting.
    Kose E; Endo H; Hori H; Hosono S; Kawamura C; Kodama Y; Yamazaki T; Yasuno N
    Pharmazie; 2022 May; 77(5):165-170. PubMed ID: 35655381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deprescribing of benzodiazepines and Z-drugs amongst the psychiatric patients of a tertiary care Hospital.
    Shilpa HSS; Kumar NN; Maheswari E; Virupaksha HS; Subeesh V; Saraswathy GR; Kunnavil R
    Asian J Psychiatr; 2019 Aug; 44():189-194. PubMed ID: 31408799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of pharmacist-led physician-supported inpatient deprescribing model in older patients admitted to an acute general medical unit.
    Potter EL; Lew TE; Sooriyakumaran M; Edwards AM; Tong E; Aung AK
    Australas J Ageing; 2019 Sep; 38(3):206-210. PubMed ID: 30868694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities.
    Ailabouni N; Mangin D; Nishtala PS
    Int J Clin Pharm; 2019 Feb; 41(1):167-178. PubMed ID: 30659492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deprescribing needs to be considered in the pharmacists' prescribing role.
    Kouladjian O'Donnell L; Sawan MJ
    Med J Aust; 2020 Feb; 212(3):141-141.e1. PubMed ID: 31868934
    [No Abstract]   [Full Text] [Related]  

  • 13. Development of a required longitudinal residency experience focused on deprescribing.
    Pruskowski J; Sakely H; Handler S
    Am J Health Syst Pharm; 2019 Feb; 76(4):236-241. PubMed ID: 31415680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Care coordination needs for deprescribing benzodiazepines and benzodiazepine receptor agonists.
    McCarthy M; Mak S; Kaufmann CN; Lum HD; Fung CH
    Res Social Adm Pharm; 2022 Apr; 18(4):2691-2694. PubMed ID: 34229951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational deprescribing in the elderly.
    Williams S; Miller G; Khoury R; Grossberg GT
    Ann Clin Psychiatry; 2019 May; 31(2):144-152. PubMed ID: 31046036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deprescribing in frail older people--Do doctors and pharmacists agree?
    Page AT; Etherton-Beer CD; Clifford RM; Burrows S; Eames M; Potter K
    Res Social Adm Pharm; 2016; 12(3):438-49. PubMed ID: 26453002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deprescribing and Tapering Benzodiazepines #355.
    Pruskowski J; Rosielle DA; Pontiff L; Reitschuler-Cross E
    J Palliat Med; 2018 Jul; 21(7):1040-1041. PubMed ID: 29975620
    [No Abstract]   [Full Text] [Related]  

  • 18. Perceptions of Nursing Facility Providers on the Utility of Deprescribing.
    Pruskowski J; Zarowitz BJ; Handler SM
    Consult Pharm; 2018 Jul; 33(7):386-402. PubMed ID: 29996968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of postoperative delirium with psychoactive medications.
    Marcantonio ER; Juarez G; Goldman L; Mangione CM; Ludwig LE; Lind L; Katz N; Cook EF; Orav EJ; Lee TH
    JAMA; 1994 Nov; 272(19):1518-22. PubMed ID: 7966844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deprescribing benzodiazepines.
    Scrandis DA; Duarte AC
    Nurse Pract; 2019 Feb; 44(2):12-14. PubMed ID: 30672861
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.